Inventor · disambiguated record
Arne Dessen
Also filed as: DESSEN ARNE
11 granted patents·9 pending applications·31 citations·filing 1995–2021
85Inventor score
Top patents by PatentIndex Score
20 records- 0186US8815831B2Treatment of Acinetobacter with alginate oligomers and antibioticsONSOYEN EDVAR·Filed 2010·Granted Aug 26, 2014·12 cites·37 claims
- 0272US9018158B2Alginate oligomers for use in overcoming multidrug resistance in bacteriaONSOYEN EDVAR·Filed 2010·Granted Apr 28, 2015·2 cites·41 claims
- 0369US9801901B2Alginate oligomers for use in overcoming multidrug resistance in bacteriaALGIPHARMA AS·Filed 2015·Granted Oct 31, 2017·1 cites·33 claims
- 0461US11712448B2Use of alginate oligomers as blood anticoagulantsALGIPHARMA AS·Filed 2014·Granted Aug 1, 2023·0 cites·35 claims
- 0561US7893038B2Oral immunostimulation of mammals birds and reptiles from (1-4) linked β-D-mannuronic acidFMC BIOPOLYMER AS·Filed 2002·Granted Feb 22, 2011·3 cites·2 claims
- 0656US11992553B2Inhalable powder formulations of alginate oligomersALGIPHARMA AS·Filed 2021·Granted May 28, 2024·0 cites·29 claims
- 0753US11385174B2Method for the qualitative and quantitative detection of alginate oligomers in body fluidsALGIPHARMA AS·Filed 2019·Granted Jul 12, 2022·0 cites·21 claims
- 0848US5573792AMethod of growing fish or crustaceans at increased conversion, growth and survival ratesISP INVESTMENTS INC·Filed 1995·Granted Nov 12, 1996·13 cites·5 claims
- 0944US10751363B2Use of aliginate oligomers and CFTR modulators in treatment of conditions associated with CFTR dysfunctionALGIPHARMA AS·Filed 2016·Granted Aug 25, 2020·0 cites·14 claims
- 1043US11413306B2Alginate oligomers for the treatment or prevention of microbial overgrowth in the intestinal tractALGIPHARMA AS·Filed 2016·Granted Aug 16, 2022·0 cites·12 claims
- 1143US2021030891A1Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layersALGIPHARMA AS·Filed 2019·Application pending·0 cites
- 1242US7816340B2Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acidFMC BIOPOLYMER AS·Filed 2002·Granted Oct 19, 2010·0 cites·9 claims
- 1342US2022305050A1Use of alginate oligomers in the anticoagulation therapy of subjects at risk of blood clots which have an abnormally dense microstructureALGIPHARMA AS·Filed 2020·Application pending·0 cites
- 1441US2018235879A1Inhalable powder formulations of alginate oligomersALGIPHARMA AS·Filed 2015·Application pending·0 cites
- 1541US2019360925A1A companion diagnostic method for use in the treatment of cystic fibrosis with alginate oligomersALGIPHARMA AS·Filed 2018·Application pending·0 cites
- 1639US2023139922A1Bacitracin-alginate oligomer conjugatesALGIPHARMA AS·Filed 2017·Application pending·0 cites
- 1734US2019328833A1Polymyxin-alginate oligomer conjugatesALGIPHARMA AS·Filed 2017·Application pending·0 cites
- 1834US2015126467A1Use of alginate oligomers to enhance the effects of antifungal agentsONSØYEN EDVAR·Filed 2012·Application pending·0 cites
- 1934US2011046085A1Oral Immunostimulation of Fish from (1-4) Linked Beta-D-Mannuronic AcidFMC BIOPOLYMER AS·Filed 2010·Application pending·0 cites
- 2022US2016361342A1Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel functionALGIPHARAMA AS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arne Dessen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →